Review
Immunology
In Kang, Yumin Kim, Heung Kyu Lee
Summary: Gamma delta T cells play important roles in tumor immunity and have potential applications in GBM treatment. However, limitations still exist and further research is needed. This review summarizes the effector functions of gamma delta T cells, current advances and limitations, and suggests future research directions.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Pharmacology & Pharmacy
Qin Xie, Jian Ding, Yi Chen
Summary: CD8(+) T lymphocytes play a crucial role in host antitumor immunity, but tumor-driven microenvironments can inhibit their activation and cytotoxicity. Stromal cells exert immunosuppressive effects in the tumor microenvironment.
ACTA PHARMACEUTICA SINICA B
(2021)
Article
Oncology
Li Xia, Enming Tian, Mingcheng Yu, Chenglong Liu, Lian Shen, Yafei Huang, Zhongen Wu, Jinlong Tian, Ker Yu, Yonghui Wang, Qiong Xie, Di Zhu
Summary: The study designed a RORγt agonist that enhances the antitumor immune response of PD-1. The agonist increased the migration of CD8(+) T cells and MoDCs in tumors, thereby promoting tumor infiltration. This study provides insights into the mechanism of RORγt agonists in immunotherapy and offers a strategy to improve the efficacy of PD-1 antibodies in cancer treatment.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2022)
Article
Chemistry, Multidisciplinary
Zeyu Yang, Liyan Li, Chengxiu Wei, Hong Liu, Dongdong Qiao, Zhenfu Wen, Haolin Chen, Shanghui Huang, Rui Guo, Zhinan Yin, Lixin Liu, Yongming Chen
Summary: A tumor vaccine has been developed that activates gamma delta T cells by fusing tumor cell membranes with lipids. This vaccine significantly inhibits tumor growth, prolongs survival time in mice, and prevents tumor recurrence after resection. The therapeutic effects are supported by TCR delta(-/-) mice and cytokine expression in the tumor.
ADVANCED FUNCTIONAL MATERIALS
(2023)
Review
Immunology
Yanan Wu, Meng Yuan, Chenlin Wang, Yanfei Chen, Yan Zhang, Jiandong Zhang
Summary: T cells play a crucial role in lung cancer therapy, and understanding their functional mechanism can lead to the discovery and development of new treatment strategies.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Cell Biology
Anna Maria Corsale, Marta Di Simone, Elena Lo Presti, Carmela Picone, Francesco Dieli, Serena Meraviglia
Summary: This article reviews recent studies on altered tumor metabolism and gamma delta T cells, emphasizing the potential of gamma delta T cells in overcoming limitations associated with conventional T cells and their anti-tumor effects. A deeper understanding of tumor metabolism and the polarization of gamma delta T cells could lead to the development of new immunotherapeutic approaches targeting tumor metabolisms.
Review
Genetics & Heredity
Renhong Zhu, Qian Yan, Yashu Wang, Keqiang Wang
Summary: This article reviews the generation and development of human gamma delta T cells, their genetic characteristics, classification, antigen recognition and role, as well as research progress in tumor immunotherapy.
FRONTIERS IN GENETICS
(2023)
Article
Oncology
Biaolong Deng, Biaolong Yang, Jieqiong Chen, Shuaiwei Wang, Weiqi Zhang, Yixian Guo, Yichao Han, Hecheng Li, Yongjun Dang, Yaqin Yuan, Xueyu Dai, Yuansheng Zang, Yangyang Li, Bin Li
Summary: This study identifies gallic acid as a compound that promotes the instability of T-reg cells, thereby enhancing the efficacy of immune checkpoint blockade (ICB) therapy in cancer treatment.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Cell Biology
Xiwei Wang, Yanmei Zhang, Yuet Chung, Chloe Ran Tu, Wenyue Zhang, Xiaofeng Mu, Manni Wang, Godfrey Chi-Fung Chan, Wing-Hang Leung, Yu-Lung Lau, Yinping Liu, Wenwei Tu
Summary: This study demonstrates that γδ T cell-derived extracellular vesicles (γδ T-EVs) have immune adjuvant effects and can be used as a tumor vaccine to improve therapeutic efficacy.
JOURNAL OF EXTRACELLULAR VESICLES
(2023)
Article
Immunology
Mei-Ling Liou, Tyler Lahusen, Haishan Li, Lingzhi Xiao, C. David Pauza
Summary: The activation of V gamma 9V delta 2 T cells can be enhanced by modifying tumor cells, leading to increased tumor suppression. The co-expression of cytokines may further boost the anti-tumor effect.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Oncology
Sarah A. O'Brien, Jessica Orf, Katarzyna M. Skrzypczynska, Hong Tan, Jennie Kim, Jason DeVoss, Brian Belmontes, Jackson G. Egen
Summary: The study found that while anti-CSF1R treatment can reduce the number of tumor-associated macrophages (TAMs), it has minimal impact on the anti-tumor immune response in established tumors. In contrast, anti-CSF1R treatment concurrent with tumor implantation can better inhibit tumor growth and enhance anti-tumor immunity.
CANCER IMMUNOLOGY IMMUNOTHERAPY
(2021)
Article
Oncology
Linyan Yu, Zhaozhong Wang, Yuan Hu, Yanan Wang, Nan Lu, Cai Zhang
Summary: Gamma delta T-cells recognize infected or transformed cells and are associated with antitumor immune response. This study found that tumor-infiltrating gamma delta T-cells exhibit functional exhaustion in colorectal cancer (CRC) and identified three distinct exhausted subsets of gamma delta T-cells. The transcription factor c-Maf was shown to play a key role in gamma delta T-cell exhaustion. These findings provide insights into the mechanisms and association of gamma delta T-cell exhaustion with tumor development and pathogenesis.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Oncology
Shengdong Wang, Hengyuan Li, Tao Chen, Hao Zhou, Wenkan Zhang, Nong Lin, Xiaohua Yu, Yu Lou, Binghao Li, Eloy Yinwang, Zenan Wang, Keyi Wang, Yucheng Xue, Hao Qu, Peng Lin, Hangxiang Sun, Wangsiyuan Teng, Haochen Mou, Xupeng Chai, Zhijian Cai, Zhaoming Ye
Summary: In this study, activated V gamma 9V delta 2 T cells were found to induce strong CD8(+) T cell responses in osteosarcoma cells and effectively suppress osteosarcoma growth in xenograft animal models. Mechanistically, activated gamma delta T cells exhibited increased HSP90 production, which upregulated MyD88 and activated JNK, leading to enhanced CD8(+) T cell cross-priming through increased CCL5 secretion. These findings suggest that V gamma 9V delta 2 T cells may serve as a promising alternative antigen-presenting cell (APC) for the development of gamma delta T cell-based tumor immunotherapy.
CANCER IMMUNOLOGY IMMUNOTHERAPY
(2023)
Review
Biochemistry & Molecular Biology
Anna Pawlowska, Yelizaveta Natochina, Witold Zardzewialy, Wiktoria Skiba, Karolina Wlodarczyk, Aleksandra Maciejczyk, Dorota Suszczyk, Iwona Wertel
Summary: This paper summarizes the existing knowledge about the phenotype and dual role of gamma delta T cells in cancers, with a focus on ovarian cancer. Ovarian cancer is one of the most lethal gynecological malignancies, and its anti-cancer immunity is modulated by the tumor microenvironment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Immunology
Rami Alfar, John V. Napoleon, Imrul Shahriar, Richard Finnell, Cole Walchle, Austin Johnson, Philip S. Low
Summary: A specific ligand targeting folate receptor delta has been discovered to effectively target regulatory T cells and inhibit tumor growth, while manipulating the polarization of tumor-infiltrating immune cells.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Cell Biology
Elena Lo Presti, Andrea De Gaetano, Giovanni Pioggia, Sebastiano Gangemi
Summary: This review comprehensively analyzes the effects of SARS-CoV-2 infection on Unconventional T cells and innate lymphoid cells (ILCs). The dysregulation of adaptive immune systems in COVID-19 affected patients has been observed, but there are still many unanswered questions regarding the behavior of Unconventional cells and ILCs during infection. This analysis highlights the differences in studies on patient cohorts and explores potential diagnostic factors and targeted therapies that have been overlooked before. Monitoring the frequencies and functions of Unconventional T cells and ILCs in longitudinal studies may provide useful prognostic biomarkers and future therapeutic strategies for SARS-CoV-2-infected individuals.
Review
Biochemistry & Molecular Biology
Alessandro Allegra, Marco Casciaro, Elena Lo Presti, Caterina Musolino, Sebastiano Gangemi
Summary: Unconventional T cells and innate lymphoid cells play important roles in autoimmune diseases, allergy, inflammation, and tumor. Some unconventional T cells have therapeutic potential and can be used as prognostic and diagnostic markers. Understanding the function of these cells is crucial for the development of new immunotherapy approaches.
Article
Pharmacology & Pharmacy
Elena Lo Presti, Laura D'Orsi, Andrea De Gaetano
Summary: The mevalonate pathway is a promising target for various research areas, and blocking this pathway with drugs like zoledronic acid can inhibit cancer cell growth. This study proposes two mathematical models to describe the kinetics of isopentenyl pyrophosphate (IPP) accumulation and its relationship with zoledronic acid treatment. The models fit the experimental data well and provide insights into the pharmacodynamics of IPP.
Article
Clinical Neurology
Mariachiara Ippolito, Giulia Spurio, Viviana Compagno, Alessandra Rizzo, Marta Di Simone, Anna Maria Corsale, Giuseppina Mazzola, Antonino Giarratano, Serena Meraviglia, Andrea Cortegiani, Antonietta Alongi
Summary: This pilot observational study evaluated the feasibility of conditional autologous serum (ACS) injections in patients with severe chronic pain and grade I-III osteoarthritis. The study also assessed the cytokine content of the ACS. The results showed a significant reduction in pain intensity after 6 months of ACS injections, suggesting that ACS may be a potential treatment option for patients with refractory osteoarthritis.
BRITISH JOURNAL OF PAIN
(2023)
Editorial Material
Biotechnology & Applied Microbiology
Anna Maria Corsale, Marta Di Simone, Francesco Dieli, Serena Meraviglia
EXPERT OPINION ON BIOLOGICAL THERAPY
(2023)
Review
Immunology
Anna Maria Corsale, Marta Di Simone, Elena Lo Presti, Francesco Dieli, Serena Meraviglia
Summary: In recent years, research has focused on implementing modern treatment approaches to improve patient survival in colorectal cancer. Gamma delta T cells are being explored as a new and promising candidate for treating various types of cancer due to their potent killing activity and ability to recognize tumor antigens independently of HLA molecules. This article specifically focuses on the role of gamma delta T cells in antitumor immunity, particularly in colorectal cancer, and highlights small-scale clinical trials in which in vivo activation or adoptive transfer of ex vivo expanded gamma delta T cells were employed for the treatment of colorectal cancer. Possible combinatorial approaches to treat colon cancer are also suggested.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Federica Plano, Emilia Gigliotta, Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Carlotta Santonocito, Manuela Ingrasci, Laura Di Carlo, Antonino Elia Augello, Maria Speciale, Candida Vullo, Cristina Rotolo, Giulia Maria Camarda, Nadia Caccamo, Serena Meraviglia, Francesco Dieli, Sergio Siragusa, Cirino Botta
Summary: Multiple myeloma (MM) is a hematologic malignancy characterized by a pro-inflammatory and immunosuppressive microenvironment. Ferritin, released by pro-inflammatory cells, contributes to ROS production and cellular damage. The study found that high ferritin levels were associated with worse prognosis in MM patients and correlated with systemic inflammation markers and specific bone marrow cell microenvironment. Bioinformatic analysis also revealed that ferritin biosynthesis gene expression signature was associated with poor outcome and specific immune cell profiles. These findings suggest that ferritin could be a potential target for improving MM patient outcome.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, Research & Experimental
Francesca Toia, Elena Lo Presti, Anna Barbara Di Stefano, Marta Di Simone, Marco Trapani, Anna Maria Corsale, Carmela Picone, Francesco Moschella, Francesco Dieli, Adriana Cordova, Serena Meraviglia
Summary: This study analysed the immunomodulatory properties of spheroids from adipose stem cells (SASCs) and compared them to adipose stem cells (ADSCs). SASCs showed stronger immunomodulatory abilities in heterologous experimental settings compared to ADSCs. SASCs also demonstrated greater anti-inflammatory properties.
Review
Medicine, General & Internal
Angela Rizzi, Elena Lo Presti, Raffaella Chini, Luca Gammeri, Riccardo Inchingolo, Franziska Michaela Lohmeyer, Eleonora Nucera, Sebastiano Gangemi
Summary: Food allergies are immune reactions to ingested or contacted foods, and they are a widespread health issue. The role of inflammatory mediators in the pathogenesis of food allergies has been studied, and some of these mediators may serve as markers for the disease or response to therapy.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Multidisciplinary Sciences
Ornella Urzi, Marco Cafora, Nima Rabienezhad Ganji, Vincenza Tinnirello, Roberta Gasparro, Samuele Raccosta, Mauro Manno, Anna Maria Corsale, Alice Conigliaro, Anna Pistocchi, Stefania Raimondo, Riccardo Alessandro
Summary: In recent years, extracellular vesicles (EVs) from various plant sources have attracted the attention of the scientific community due to their interesting biological properties. This study isolated and characterized nano-vesicles from lemon juice (LNVs) and investigated their antioxidant effects. LNV pre-treatment reduced ROS levels in fibroblasts stimulated with H2O2 and UVB, and this reduction was associated with the activation of the AhR/Nrf2 signaling pathway. In zebrafish embryos, LNVs also exhibited antioxidant effects by reducing ROS levels and neutrophil migration when stimulated with LPS.
Review
Hematology
Federica Plano, Anna Maria Corsale, Emilia Gigliotta, Giulia Camarda, Candida Vullo, Marta Di Simone, Mojtaba Shekarkar Azgomi, Maria Speciale, Melania Carlisi, Nadia Caccamo, Francesco Dieli, Serena Meraviglia, Sergio Siragusa, Cirino Botta
Summary: Multiple myeloma (MM) is an incurable hematologic malignancy with a multistep evolutionary pathway, involving monoclonal gammopathy of undetermined significance (MGUS), smoldering MM (sMM), and symptomatic MM. Genomic alterations are present at the MGUS phase, but their role in disease evolution is questionable. Changes in the bone marrow microenvironment (TME) play a key role in MM evolution, driving cancer progression and clonal plasma cell behavior. Microenvironment-oriented drugs have significantly improved MM patients' survival. This review discusses the role of the TME in MM evolution and potential therapeutic targets/opportunities.
HEMATOLOGY REPORTS
(2023)
Meeting Abstract
Oncology
Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Federica Plano, Emilia Gigliotta, Marta Di Simone, Maria Speciale, Candida Vullo, Miriam Sciortino, Fulvio Brucato, Francesca Buffa, Nadia Caccamo, Francesco Dieli, Serena Meraviglia, Sergio Siragusa, Cirino Botta
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
(2023)
Meeting Abstract
Oncology
Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Federica Plano, Marta Di Simone, Cristina Perez, Carmela Picone, Emilia Gigliotta, Maria Speciale, Candida Vullo, Giulia Camarda, Cristina Rotolo, Marco Santoro, Nadia Caccamo, Bruno Paiva, Sergio Siragusa, Francesco Dieli, Serena Meraviglia, Cirino Botta
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
(2023)
Meeting Abstract
Oncology
Emilia Gigliotta, Andrea Rizzuto, Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Maria Speciale, Giulio Giannone, Alessandro Fidenco, Federica Vernuccio, Ada Maria Florena, Francesco Dieli, Serena Meraviglia, Giuseppe Brancatelli, Roberto Cannella, Sergio Siragusa, Cirino Botta
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
(2023)
Review
Cell Biology
Leila Mohammadnezhad, Mojtaba Shekarkar Azgomi, Marco Pio La Manna, Guido Sireci, Chiara Rizzo, Giusto Davide Badami, Bartolo Tamburini, Francesco Dieli, Giuliana Guggino, Nadia Caccamo
Summary: This article discusses the role of immunometabolism in autoimmune diseases and its impact on disease development, as well as proposes various immunotherapeutic approaches.